Affini-T Therapeutics Competitors and Similar CompaniesClear all

On Target Laboratories's competitors and similar companies include Proteina, Castle Biosciences and GeneCentric Therapeutics.
On Target Laboratories
On Target Laboratories
On Target Laboratories is a biotechnology company that discovers and develops tumor-targeted fluorescent dyes for cancer surgery.
Proteina
Proteina
Proteina is a company developing "Protein-Protein Interaction Profiling"(PPI) technology.
Castle Biosciences
Castle Biosciences
Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers.
GeneCentric Therapeutics
GeneCentric Therapeutics
GeneCentric Therapeutics is a company providing technology to identify drug responder populations that enable the development of precision cancer drugs.
Founding Date
Founding Date
2010
Founding Date
N/A
Founding Date
2008
Founding Date
2011
Type
Type
Private
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
West Lafayette, US HQ
Locations
KR HQ
Locations
Friendswood, US HQ
Phoenix, US
Locations
Durham, US HQ
Employees
Employees
556% increase
Employees
N/A
Employees
61013% increase
Employees
12

Funding

Latest funding round
Latest funding round
$ 21m (over 5 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 6.1m (over 9 years ago)
Total funding raised
Total funding raised
$ 81.7m
Total funding raised
N/A
Total funding raised
$ 46.5m
Total funding raised
$ 6.1m
For sources of this data, please see the company profile

View Company Profiles

Proteina
HQ
KR

Proteina is a company developing "Protein-Protein Interaction Profiling"(PPI) technology.

View company
Castle Biosciences
HQ
Friendswood, US
Employees
610↑ 13% increase

Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers.

View company
GeneCentric Therapeutics
HQ
Durham, US
Employees
12

GeneCentric Therapeutics is a company providing technology to identify drug responder populations that enable the development of precision cancer drugs.

View company